logo
  

China Gives Antitrust Clearance For Analog Devices' Acquisition Of Maxim - Quick Facts

Analog Devices, Inc. (ADI) and Maxim Integrated Products, Inc. (MXIM) said they anticipate their merger will close on or about August 26, 2021 as the deal has now received all required regulatory clearances. On Monday, China's State Administration for Market Regulation has given antitrust clearance for Analog Devices' acquisition of Maxim.

In July 2020, Analog Devices and Maxim entered into a definitive agreement under which ADI will acquire Maxim in an all stock transaction that values the combined enterprise at over $68 billion. In October, ADI and Maxim shareholders approved the proposals relating to the combination.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's Cyltezo as the first interchangeable biosimilar to AbbVie's top-selling drug Humira or adalimumab. Cyltezo, originally approved in August 2017, is both biosimilar to, and interchangeable with Humira for Cyltezo's approved uses. The Food and Drug Administration may be planning to allow people to receive Covid-19 vaccine booster shot that is different from the initial dose, reports indicate. The agency is likely to make the announcement on mix and match approach on coronavirus booster vaccines on Wednesday. The move will be part of FDA's expected authorization of boosters for the Moderna and Johnson & Johnson vaccines. Drug major Johnson & Johnson on Tuesday raised again its forecast for fiscal 2021 earnings and sales, which are above market view, after reporting higher results in the third quarter. The company's quarterly adjusted earnings also beat market estimates. In pre-market activity on the NYSE, JNJ shares were gaining around 1.24 percent to trade at $162.10.
Follow RTT